Andy Eberding
Impact in
- Pharmacology top 5%
- Pharmacological Effects of Natural Compounds
- Apelin-related biomedical research
Papers in
-
- Natural product bioactivities and synthesis 2
- Ginseng Biological Effects and Applications 2
- Co-authors
- Emma S. Tomlinson Guns (6 shared papers)Dong Sheng Ming (2 shared papers)G.H.N. Towers (2 shared papers)Ladan Fazli (4 shared papers)Hans Adomat (4 shared papers)Catherine A. Wood (4 shared papers)Emma Tomlinson Guns (3 shared papers)William Jia (3 shared papers)
- Journals
- The Journal of Urology (2 papers)Cancer Chemotherapy and Pharmacology (2 papers)Nutrition and Cancer (1 paper)Phytotherapy Research (1 paper)The Prostate (1 paper)
- Partner nations
- CanadaGermanyUnited Kingdom
In The Last Decade
Andy Eberding
10 papers receiving 335 citations
Peers
Comparison fields: 5 of 65
- Pharmacology 146
- Complementary and alternative medicine 42
- Molecular Biology 274
- Pharmacology 52
- Endocrinology, Diabetes and Metabolism 40
Countries citing papers authored by Andy Eberding
This map shows the geographic impact of Andy Eberding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andy Eberding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andy Eberding more than expected).
Fields of papers citing papers by Andy Eberding
This network shows the impact of papers produced by Andy Eberding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andy Eberding. The network helps show where Andy Eberding may publish in the future.
Co-authors
The 23 scholars most cited alongside Andy Eberding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 98 | |
| 2 | 2006 | 56 | |
| 3 | 2005 | 49 | |
| 4 | 2009 | 43 | |
| 5 | 2012 | 33 | |
| 6 | 2010 | 26 | |
| 7 | 2004 | 25 | |
| 8 | 2007 | 8 | |
| 9 | 2007 | 7 | |
| 10 | 2004 | 4 |
About Andy Eberding
Andy Eberding is a scholar working on Molecular Biology, Pharmacology, Oncology, Pathology and Forensic Medicine and Pollution, having authored 10 papers that have together received 349 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (2 papers), Natural product bioactivities and synthesis (2 papers), Ginseng Biological Effects and Applications (2 papers), Phytochemistry and Biological Activities (1 paper), Trace Elements in Health (1 paper), Poisoning and overdose treatments (1 paper), Traditional and Medicinal Uses of Annonaceae (1 paper) and Tea Polyphenols and Effects (1 paper). The work is most often cited by research in Pharmacology (146 citations), Complementary and alternative medicine (42 citations), Molecular Biology (274 citations), Pharmacology (52 citations) and Endocrinology, Diabetes and Metabolism (40 citations). Andy Eberding has collaborated with scholars based in Canada, Germany and United Kingdom. Frequent co-authors include Emma S. Tomlinson Guns, Dong Sheng Ming, G.H.N. Towers, Ladan Fazli, Hans Adomat, Catherine A. Wood, Emma Tomlinson Guns, William Jia, Sherwin Xie and Selvarani Vimalanathan. Their work appears in journals such as The Journal of Urology, Cancer Chemotherapy and Pharmacology, Nutrition and Cancer, Phytotherapy Research and The Prostate.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.